Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 90 member A27, pseudogene (FAM90A27P) is classified as a pseudogene in the human genome and does not encode a well-characterized functional protein. While some sources mention possible associations with biological processes such as signal transduction, apoptosis, and cell differentiation, the majority of public gene annotation databases (GeneCards, NCBI, Ensembl, etc.) list FAM90A27P as a pseudogene, meaning it is generally not transcribed into a functional protein and lacks proven therapeutic relevance. Consequently, FAM90A27P is not considered a therapeutic target (such as receptor, enzyme, transporter, etc.), and there is limited or no reliable evidence of active biological functions, disease involvement, drug interactions, or clinical biomarkers in the scientific literature. Any mention of functions or disease associations is either speculative or based on data from paralogs, not FAM90A27P itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A27, pseudogene (FAM90A27P).